CN Stock MarketDetailed Quotes

Suzhou Zelgen Biopharmaceuticals (688266)

Watchlist
  • 93.33
  • +1.73+1.89%
Market Closed Mar 26 15:00 CST
24.71BMarket Cap-185.18P/E (TTM)

Suzhou Zelgen Biopharmaceuticals (688266) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Drugs375.54M99.97%
医药中间体及原辅料92.71K0.02%
Asset lease15.29K0.00%

By Industry

Currency:CNY
2025/H1
Stock NameRevenueRatio
Drugs375.54M99.97%
医药中间体及原辅料92.71K0.02%
Asset lease15.29K0.00%

By Country/Region

Currency:CNY
2025/H1
Stock NameRevenueRatio
Territory area375.65M100.00%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the prospect of a ceasefire negotiation between the US and Iran has been dominating market sentiment. On March 26 EST, President T Show More